R
Redx Pharma PLC
LSE:REDX
Redx Pharma PLC
LSE:REDX
Price:
15
GBX
31.58%
Market Cap:
£50.2m
Balance Sheet
Balance Sheet Decomposition
Redx Pharma PLC
Redx Pharma PLC
Balance Sheet Decomposition is not available for
Redx Pharma PLC
Redx Pharma PLC
Balance Sheet
Redx Pharma PLC
Redx Pharma PLC
Currency: GBP
| Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
9
|
6
|
24
|
6
|
4
|
28
|
30
|
54
|
18
|
|
| Cash |
0
|
3
|
0
|
0
|
6
|
0
|
28
|
21
|
54
|
18
|
|
| Cash Equivalents |
3
|
6
|
6
|
24
|
0
|
4
|
0
|
9
|
0
|
0
|
|
| Total Receivables |
2
|
0
|
2
|
3
|
2
|
2
|
0
|
3
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
2
|
3
|
0
|
1
|
0
|
3
|
0
|
0
|
|
| Other Receivables |
2
|
0
|
1
|
1
|
2
|
1
|
0
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
1
|
0
|
2
|
3
|
5
|
5
|
|
| Total Current Assets |
12
|
1
|
8
|
27
|
10
|
6
|
29
|
36
|
59
|
23
|
|
| PP&E Net |
0
|
0
|
1
|
0
|
0
|
4
|
3
|
3
|
3
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
2
|
|
| Accumulated Depreciation |
0
|
1
|
0
|
0
|
1
|
0
|
2
|
2
|
3
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
14
N/A
|
0
N/A
|
9
N/A
|
28
+195%
|
10
-63%
|
10
-4%
|
33
+234%
|
40
+20%
|
62
+58%
|
26
-59%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
2
|
6
|
13
|
2
|
3
|
2
|
2
|
3
|
1
|
|
| Accrued Liabilities |
0
|
2
|
0
|
0
|
2
|
0
|
2
|
3
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
7
|
4
|
5
|
1
|
|
| Total Current Liabilities |
4
|
4
|
8
|
13
|
4
|
5
|
11
|
10
|
27
|
21
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
20
|
17
|
2
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
0
N/A
|
8
N/A
|
13
+74%
|
5
-66%
|
8
+84%
|
31
+269%
|
26
-15%
|
29
+10%
|
22
-24%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
|
| Retained Earnings |
6
|
0
|
22
|
20
|
29
|
33
|
42
|
59
|
73
|
103
|
|
| Additional Paid In Capital |
14
|
0
|
23
|
33
|
33
|
33
|
37
|
66
|
100
|
100
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
4
|
4
|
|
| Total Equity |
8
N/A
|
0
N/A
|
2
N/A
|
14
+733%
|
6
-60%
|
1
-74%
|
2
+36%
|
13
+548%
|
33
+154%
|
3
-90%
|
|
| Total Liabilities & Equity |
14
N/A
|
0
N/A
|
9
N/A
|
28
+195%
|
10
-63%
|
10
-4%
|
33
+234%
|
40
+20%
|
62
+58%
|
26
-59%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
65
|
0
|
94
|
127
|
127
|
127
|
195
|
275
|
335
|
335
|
|
Switch to:
Switch to:
See Also
Discover More
